Published on: November 29, 2017 at 10:30PM
Conditions: Prostate Cancer; Castration-resistant Prostate Cancer; Drug
Interventions: Drug: Abiraterone Acetate; Drug: Docetaxel
Sponsor: West China Hospital
Not yet recruiting
http://ift.tt/2AipvnT
New cancer clinical trial: Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate
Tag: cancer Clinical Trials
No comments: